pubmed-article:6297202 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6297202 | lifeskim:mentions | umls-concept:C0017710 | lld:lifeskim |
pubmed-article:6297202 | lifeskim:mentions | umls-concept:C1417838 | lld:lifeskim |
pubmed-article:6297202 | lifeskim:mentions | umls-concept:C1706204 | lld:lifeskim |
pubmed-article:6297202 | lifeskim:mentions | umls-concept:C1555721 | lld:lifeskim |
pubmed-article:6297202 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:6297202 | pubmed:dateCreated | 1983-3-11 | lld:pubmed |
pubmed-article:6297202 | pubmed:abstractText | In patients with deficient endogenous glucocorticoid production due to primary adrenal insufficiency (n = 4) or bilateral adrenalectomy (n = 2) a rise in LRH-stimulated concentrations of LH was seen following withdrawal of substitution therapy for 84 h. Consecutive re-administration of glucocorticoids (dexamethasone 2.0 mg/day for 3 days) resulted in increased basal concentrations of LH and FSH and a diminished secretory response of LH upon iv LRH (100 micrograms). Five patients substituted with glucocorticoids because of adrenocortical insufficiency presented upon the administration of exogenous ACTH1-24 with unchanged basal and LRH-stimulated concentrations of LH and FSH as compared to a placebo experiment. These data suggest that the withdrawal and subsequent re-administration of gluco-corticoid substitution alters basal and stimulated concentrations of gonadotrophins in patients with adrenocortical insufficiency, thus providing evidence for the importance of adequate glucocorticoid supply in the regulation of gonadotrophin secretion. | lld:pubmed |
pubmed-article:6297202 | pubmed:language | eng | lld:pubmed |
pubmed-article:6297202 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6297202 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6297202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6297202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6297202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6297202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6297202 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6297202 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6297202 | pubmed:month | Dec | lld:pubmed |
pubmed-article:6297202 | pubmed:issn | 0001-5598 | lld:pubmed |
pubmed-article:6297202 | pubmed:author | pubmed-author:NowotnyPP | lld:pubmed |
pubmed-article:6297202 | pubmed:author | pubmed-author:WaldhäuslWW | lld:pubmed |
pubmed-article:6297202 | pubmed:author | pubmed-author:VierhapperHH | lld:pubmed |
pubmed-article:6297202 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6297202 | pubmed:volume | 101 | lld:pubmed |
pubmed-article:6297202 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6297202 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6297202 | pubmed:pagination | 580-5 | lld:pubmed |
pubmed-article:6297202 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:meshHeading | pubmed-meshheading:6297202-... | lld:pubmed |
pubmed-article:6297202 | pubmed:year | 1982 | lld:pubmed |
pubmed-article:6297202 | pubmed:articleTitle | Gonadotrophin-secretion in adrenocortical insufficiency: impact of glucocorticoid substitution. | lld:pubmed |
pubmed-article:6297202 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6297202 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:6297202 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6297202 | lld:pubmed |